ARTAIRA Arterial Compression Device for Gentle Therapy, Enhance Circulation, Supports Wound Healing

Trusted Therapy. Proven Science. Real Relief.

The ARTAIRA Arterial Compression Device Complete System with Two Leg Sleeves — an FDA-cleared intermittent pneumatic compression (IPC) system engineered to increase arterial blood flow in patients with symptoms of Peripheral Arterial Disease (PAD) and Chronic Limb-Threatening Ischemia (CLTI). Through rapid, high-pressure inflation and deflation cycles, ARTAIRA enhances circulation, supports wound healing, reduces rest pain, and helps patients walk farther with greater comfort, improving quality of life and potentially reducing the need for amputation.

How ARTAIRA Works

The device delivers 120 mmHg rapid, sequential compression to the foot, ankle, and calf in a repeating 20-second cycle:

• Foot/Ankle inflation (3 seconds)
• Calf inflation (3 seconds)
• Deflation/Rest (17 seconds)
• These repetitive inflation/deflation sequences mimic fast walking, without pain. Venous blood is emptied in the small vessels, allowing arterial blood to more easily flow to the feet and toes. This type of compression therapy could provide long-term blood flow enhancements – and even heal ulcers and potentially prevent amputation.

A Non-Invasive Therapy for Complex Arterial Disease

ARTAIRA is designed to help extend arterial therapy beyond the office, offering a non-invasive option for patients with challenging circulation conditions. Intermittent Pneumatic Compression (IPC) has been shown to support patients with arterial disorders, particularly when traditional revascularization options are limited. Clinical guidance, including a 2024 Clinical Practice Guideline published in the Journal of the American College of Cardiology, recognizes arterial IPC as a potential therapy to help augment wound healing and relieve ischemic rest pain in patients with chronic limb-threatening ischemia.